The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.

Guests

  • Dr. Paul Antony chief medical officer for the Pharmaceutical Research and Manufacturers of America
  • Dr. Janet Woodcock deputy commissioner and chief medical officer of the FDA
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Barry Meier: “Missing Man”

Tuesday, May 24 2016Nine years ago, former FBI agent Robert Levinson disappeared in Iran while on a mission for the CIA. The story of his secret journey to Iran, the CIA cover-up that followed and efforts to rescue the longest-held U.S. hostage.

The U.S. Expands Ties To Vietnam

Tuesday, May 24 2016President Barack Obama lifts the embargo against U.S. arms sales to Vietnam. We discuss what closer ties between the U.S. and Vietnam mean for trade, leverage on human rights and growing concerns over China's military expansion.